Related by context. All words. (Click for frequent words.) 75 histamine dihydrochloride 68 generation purine nucleoside 67 apoptosis inducers 67 molecular imaging radiopharmaceutical 67 PDX pralatrexate 67 oral prodrug 67 targeted radiotherapeutic 67 Zemiva TM 66 liposomal formulation 66 Junovan TM 66 Spiegelmer ® 66 ARIKACE ™ 66 Allovectin 7 66 Civacir 65 Amrubicin 65 Fx #A 65 XL# XL# 65 Fodosine 65 PDE4 inhibitor 65 OvaRex R 65 mitogen activated ERK kinase 65 Ceplene 65 virus HCV protease inhibitor 65 Panzem R 65 Annamycin 65 Personalized Immunotherapy 65 BLA filing 65 Panzem R NCD 65 refractory chronic lymphocytic 65 Phase IIb clinical trials 65 KRYSTEXXA TM pegloticase 64 Valtropin 64 ocular formulation 64 Iluvien ® 64 MOVIPREP R 64 FOLOTYN ® 64 PNP inhibitor 64 acyclovir Lauriad R 64 TBC# 64 muscarinic receptor agonist 64 receptor tyrosine kinase inhibitor 64 THR beta agonist 64 OvaRex ® MAb 64 Soliris TM eculizumab 64 anticancer compound 64 novel emulsion formulation 64 ruxolitinib 64 StaphVAX R 64 Archexin 64 apoptosis inducer 64 PANVAC VF 64 2A receptor agonist 64 2 methoxyestradiol 64 cancer immunotherapies 64 Solazed 64 Anidulafungin 64 Exherin 63 Ceplene histamine dihydrochloride 63 Anturol ® 63 personalized immunotherapy 63 Vascular Wrap TM 63 Zemiva ™ 63 TELINTRA 63 ACAPODENE TM 63 Oasmia 63 XL# anticancer compounds 63 Phase #b/#a clinical 63 Marketing Authorisation Application 63 intravenous acetaminophen 63 torsemide ER 63 intravenous AAT 63 Loramyc R 63 afamelanotide 63 nalbuphine ER 63 SinuNase TM 63 EcoNail TM 63 Prodarsan R 63 non nucleoside inhibitor 63 Proxinium TM 63 miconazole Lauriad 63 ALN PCS 63 sodium glucose transporter 63 Polymer Microspheres 63 Troxatyl TM 63 Vascular Disrupting Agent 63 Factor VIIa 63 ospemifene 63 Xcytrin R 63 SPL# Gel vaginal microbicide 63 JZP 63 histone deacetylase HDAC inhibitor 63 Qutenza TM 63 Onalta ™ 63 Evoltra ® 63 Peginterferon alfa 2b 63 investigational humanized monoclonal antibody 63 SPRYCEL ® 63 SYCREST 63 Evoltra R 63 PI3K/Akt pathway inhibitor 63 IV APAP 63 Tarmogen 63 PEGylated interferon 63 selective estrogen receptor modulator 63 Cinryze ™ 63 hypoxia activated prodrug 63 acetonide FA 63 candidate REP# 62 HepeX B 62 cetuximab Erbitux R 62 recombinant biopharmaceutical 62 Octreotide 62 anti CD3 monoclonal 62 initiated Phase Ib 62 Zenvia ™ 62 topically applied SEPA 62 Plicera 62 Dyloject TM 62 BiovaxID TM 62 Cloretazine ® 62 including eniluracil ADH 62 ZEVALIN ® 62 Angiocept 62 alvespimycin 62 intranasal formulation 62 RANK Ligand inhibitor 62 forodesine 62 DPP4 inhibitor 62 Increlex TM 62 SinuNase ™ 62 MKC# MT 62 Initiates Clinical 62 AAG geldanamycin analog 62 Ganciclovir 62 LymphoStat B TM 62 IV acetaminophen 62 HGS# 62 markets HP Acthar 62 DPX Survivac 62 Solazed TM 62 candidate AQ4N 62 BENLYSTA ® 62 QNEXA ® 62 Icatibant 62 selective immunoproteasome inhibitor 62 vosaroxin 62 polysaccharide polymer 62 Loramyc 62 DXL# 62 midstage trials 62 Phase #b/#a trial 62 Omigard 62 pan HDAC inhibitor 62 phase IIb trial 62 Silodosin 62 radiotherapeutic 62 IMPDH inhibitor 62 Rapinyl 62 novel histone deacetylase 62 dermatology biopharmaceutical company 62 trastuzumab DM1 T DM1 62 Onco TCS 62 YONDELIS 62 Specifid 62 SUTENT ® 62 delivers fluocinolone acetonide FA 62 JAK inhibitor 62 LymphoStat B belimumab 62 TELINTRA R 62 telomerase therapeutic 62 non nucleoside HCV 62 Ketotransdel 62 Nasdaq VNDA 62 volociximab 62 Generx ™ 62 Mepact 62 thalidomide Thalomid 62 Panzem NCD 62 Biologic License Application BLA 62 rALLy clinical trial 62 Xanafide 62 Acetavance TM 62 IRX 2 62 LE SN# 62 midstage clinical 62 ATL/TV# 61 Cleviprex TM clevidipine 61 tubulin inhibitor 61 EOquin 61 apricitabine ATC 61 CD# CEA 61 epigenetic therapies 61 FACTIVE R gemifloxacin 61 Linjeta TM 61 ASONEP TM 61 Velcade bortezomib 61 HDL Mimetic Peptide 61 VitiGam 61 Receives Orphan Drug Designation 61 reslizumab 61 Myocet 61 IMA# 61 rolapitant 61 mertansine 61 Exherin TM 61 lexidronam injection 61 Somatuline R Autogel R 61 BEMA Granisetron 61 intranasal insulin product 61 SILENOR 61 Levoleucovorin 61 Febuxostat 61 Retacrit 61 IAP inhibitor 61 Soliris eculizumab 61 CRMD# 61 EVIZON ™ 61 oral proteasome inhibitor 61 RhuDex ® 61 TAFA# 61 anti infective treatments 61 Zybrestat 61 ALTROPANE R 61 Panzem 61 Luteinizing Hormone Releasing Hormone 61 LibiGel ® 61 RH1 61 ATPace TM 61 leading oral taxane 61 Vion Pharmaceuticals 61 Trofex TM 61 Urocidin 61 Initiates Enrollment 61 CCR5 antagonist 61 Sphingomab TM 61 XOMA 3AB 61 dasatinib Sprycel ® 61 Kamada AAT 61 acyclovir Lauriad ® 61 rhThrombin 61 ATL# [002] 61 Degarelix 61 Ambrisentan 61 OncoVex 61 novel therapeutic antibodies 61 PREOS R 61 candidate Zemiva TM 61 Nexavar sorafenib 61 Alfacell proprietary ribonuclease 61 supplemental biologics 61 Davanat 61 TLR9 agonist 61 TLK# 61 Ereska 61 MAGE A3 ASCI 61 GVAX ® 61 NEBIDO R 61 aerosolized AAT 61 rxRNA 61 IMiDs R 61 miconazole Lauriad ® 61 Clolar ® 61 Aurora kinase inhibitor 61 miconazole Lauriad R 61 Clevudine 61 Initiates Phase II 61 PRT# 61 Orphan Drug designations 61 Completes Patient Enrollment 61 YONDELIS R 61 Alzhemed TM 61 Onconase 61 IND submission 61 candidate deforolimus 61 antibody MAb 61 Q#IR 61 HuMax CD4 61 CYT# vascular disrupting 61 tiapamil 61 AQ4N 61 FavId 61 DIFICID ™ 61 orally administered inhibitor 61 isoform selective 61 investigational antiplatelet agent 61 Insegia 60 TKM ApoB 60 Onalta 60 Opterone R 60 immunotherapeutic vaccine 60 CEQ# 60 Vertex hepatitis C 60 neuronal nicotinic receptor NNR 60 methylnaltrexone bromide 60 Voraxaze 60 forodesine hydrochloride 60 Adenoscan R 60 Locteron ® 60 Firazyr 60 #D#C# 60 ATryn ® 60 successfully commercialize Iluvien 60 compound perifosine 60 GLP toxicology studies 60 Augment TM 60 Synavive ™ 60 GALNS 60 GEM OS2 60 sterile lidocaine patch 60 PHX# 60 oncolytic virus therapies 60 SNT MC# 60 Cloretazine R 60 investigational pan BCR 60 CB2 selective receptor agonist 60 oral ridaforolimus 60 motexafin gadolinium Injection 60 Anturol TM 60 CINOD 60 vapreotide acetate 60 Announces Poster Presentations 60 HCV protease inhibitors 60 seliciclib CYC# 60 sodium thiosulfate STS 60 HQK 60 bevacizumab Avastin R 60 pradefovir 60 phase IIa clinical 60 VNP#M 60 Cetrorelix 60 GW# [003] 60 mesylate 60 vascular disrupting agent 60 Kosan dependence 60 Aflibercept 60 TheraCIM 60 Pyridorin 60 Hematide ™ 60 cutaneous T 60 Chemokine Therapeutics 60 incyclinide 60 XP# XP# 60 AEG# 60 candidate iSONEP TM 60 PREOS 60 Noxafil 60 alemtuzumab Campath 60 pralatrexate injection folate analogue 60 R sorafenib tablets 60 Files IND 60 Phase III Clinical Trial 60 omacetaxine mepesuccinate 60 Saforis 60 phase IIb clinical 60 Squalamine 60 DEB# 60 investigational HCV polymerase 60 prokinetic agent 60 proteasome inhibitor 60 diarrhea predominant irritable 60 OMP designation 60 PEP# [003] 60 MyVax R 60 Cloretazine 60 UPLYSO 60 Omacetaxine 60 Marketing Authorisation Application MAA 60 Nanobody ® 60 HCV polymerase 60 AzaSite Plus 60 Friedreich Ataxia FRDA 60 brentuximab vedotin SGN 60 Oracea TM 60 Pivotal Phase III 60 Phase IIa trial 60 CYT# potent vascular disrupting 60 multi kinase inhibitor 60 IL# PE#QQR 60 trastuzumab DM1 60 ionotropic glutamate receptor antagonists 60 obatoclax 60 tosedostat 60 MAA submission 60 IgG1 monoclonal antibody 60 Emezine 60 Nitec 60 novel anticancer 60 Vantas 60 Pradefovir 60 IMiD 60 GRNVAC1 60 Evoltra TM 60 therapeutic monoclonal antibody 60 herpetic keratitis 60 Application MAA 60 Yondelis ® 60 Initiates Clinical Trial 60 Nanobody 60 Unit Dose Budesonide 60 docetaxel Taxotere R 60 Azedra TM 60 Aloxi R 60 dextromethorphan quinidine 60 valtorcitabine 60 peptidomimetic 60 DOS# 60 BCX# 60 novel peptides 60 Rhucin R 60 TOCOSOL 60 pharmacokinetic PK study 60 novel immunotherapies 60 peripherally acting 60 SEBIVO 60 Solasia 60 Tyzeka Sebivo 60 antisense inhibitors 60 Meets Primary Endpoint 60 glucokinase activator 60 inhaled formulation 60 P#X# antagonist 59 ILUVIEN ® 59 PGL# 59 inhaled antibiotic 59 Modrenal R 59 TRO# 59 phase IIb III 59 GTC recombinant form 59 histone deacetylase HDAC 59 Phase Ib study 59 Nicotine Conjugate Vaccine 59 CCR9 antagonist 59 EndoTAG 59 Allovectin 7 r 59 etanercept Enbrel 59 candidate CRLX# 59 candidates Azedra TM 59 Frova ® 59 TKB# 59 personalized dendritic 59 Initiates Phase III 59 highly selective inhibitor 59 Pegloticase 59 Gleevec imatinib mesylate 59 EOquin TM 59 vaccines oncolytic virus 59 Dacogen injection 59 Orally administered 59 Trofex 59 Generx TM 59 Japanese Encephalitis vaccine 59 Homspera ® 59 lucinactant 59 PrevOnco 59 OMAPRO 59 PROSTVAC ® 59 SAR# [002] 59 Velac 59 BRILINTA 59 investigational pharmacologically unique 59 plasma kallikrein inhibitor 59 lumiliximab 59 Corlux 59 TRANSDUR Bupivacaine 59 ONTAK 59 gastrointestinal disorders ATI 59 PLK1 SNALP 59 HCV antiviral 59 Silenor ® 59 Fc fusion protein 59 RenaZorb TM 59 Phase III Clinical Trials 59 HuMax TAC 59 TPI ASM8 59 Pazopanib 59 drug ISA# 59 pancreatic enzyme replacement 59 triciribine phosphate monohydrate 59 Firdapse 59 Omigard TM 59 IND Investigational New 59 Tarceva TM 59 Immunotherapeutic 59 targeted antifolate 59 adalimumab Humira 59 faropenem medoxomil 59 ENMD # 59 highly selective adenosine 59 MEK inhibitor 59 Mycograb 59 Nexavar ® 59 protein tyrosine phosphatase 1B 59 FDA Accepts 59 mapatumumab 59 tramiprosate Alzhemed TM 59 INS# [001] 59 baminercept 59 highly selective endothelin 59 octreotide implant 59 ALN TTR 59 lintuzumab SGN 59 Trobalt 59 TNF Tumor Necrosis Factor 59 Potelligent Technology 59 R Saizen R 59 ATL# [001] 59 atacicept 59 PSN# [002] 59 T Pred 59 signal transduction inhibitor 59 subsidiaries visit http:/www.apricusbio.com 59 Hsp# Inhibitor 59 ProtAffin 59 Bendamustine 59 Maxy G# 59 ANTEGREN 59 Nebido 59 miconazole MBT 59 inhaled AAT 59 Raptiva R 59 Simulect 59 Preclinical studies suggest 59 Cimzia ® certolizumab pegol 59 Aryplase 59 Maribavir 59 MAb therapy 59 small molecule chemotherapeutic 59 telaprevir VX 59 cathepsin K inhibitor 59 Tezampanel 59 Stimuvax R 59 HepeX B TM 59 Arno Therapeutics 59 Plenaxis R 59 POSIDUR TM ELADUR TM 59 Cutanea Life Sciences 59 XIAFLEX ™ 59 Vicinium TM 59 epothilone 59 telomerase inhibitor drug 59 Glybera 59 FOLFOX6 chemotherapy regimen 59 Announces Tentative Approval 59 aldehyde dehydrogenase ALDH2 deficiency 59 investigational hepatitis B 59 Viramidine 59 Pruvel TM 59 Multiferon R 59 oral talactoferrin 59 Solazed ™ 59 XL# XL# XL# XL# 59 personalized dendritic cell 59 Evoltra 59 candidates Dyloject TM 59 photoprotective drug 59 phase III isavuconazole 59 RIGScan CR 59 outlicensed 59 nitric oxide donating prostaglandin 59 Zensana TM 59 VALSTAR 59 HCV polymerase inhibitor 59 Calixa 59 Tumour Vascular Disrupting Agent 59 Cutanea 59 Glybera R 59 MT#/MEDI-# 59 Initiate Clinical Trial 59 selective adenosine 59 BrachySil 59 GTC recombinant human 59 eniluracil 59 Rhucin ® recombinant 59 LHRH antagonist 59 Serdolect ® 59 Romiplostim 59 dalbavancin 59 PrevOnco ™ 59 Ostabolin C TM 59 Lovaza TM 59 KRN# 59 celgosivir 59 tanespimycin 59 EndoTAG TM -1 59 hoFH 59 Nexavar tablets 59 Diabetic Macular Edema DME 59 Presents Preclinical Data 59 VISICOL R 59 MEK inhibitor RDEA# 59 Receives Approvable Letter 59 Bonefos 59 liver resection surgeries 59 naronapride 59 selective modulator 59 Enjuvia 59 multicenter Phase II 59 Triapine R 59 ELIQUIS 59 CONBRIZA 59 oral isotype selective HDAC 59 Cannabinor 59 generation proteasome inhibitor 59 Marketing Authorization Application MAA 59 ATG Fresenius S 59 OHR/AVR# 59 Zensana 59 Pancreate 59 orBec 59 Staccato nicotine technology 59 EVIZON TM 59 Cethrin R 59 ZK EPO 59 investigational monoclonal antibody 59 Targeted Chemotherapy 59 selective androgen receptor modulator 59 GATTEX TM 59 RhuDex TM 59 CRD5 59 Therapeutic Competitors Companies 59 Ceflatonin R 59 Drug Eluting Stent System 59 Campath ® 59 docetaxel Taxotere ® 59 TRACON Pharmaceuticals 59 Revlimid lenalidomide 59 Theratope 59 TOCOSOL Camptothecin 59 alkylating agent 59 PROVENGE ® 59 anti botulism antibody 59 defensin mimetic antibiotic 59 Carfilzomib 59 ixabepilone 59 Zenpep 59 Zorbtive TM 59 M Enoxaparin 59 topical anti infective 59 Anticalin R 59 CDP# 58 Deforolimus 58 Panzem ® 58 Adenuric R 58 Kalbitor 58 Plenaxis TM 58 Romidepsin 58 NEBIDO 58 Removab 58 sNDAs 58 TOCOSOL Paclitaxel 58 goserelin 58 Actimmune ® 58 Phase IIb trials 58 targets Galectin receptors 58 HSP# inhibitor 58 Marqibo 58 kidney urologic 58 Vitrasert R 58 bevacizumab Avastin ® 58 balsalazide tablet 58 confirmatory Phase III 58 Intravenous Human 58 IL-#/# 58 therapeutic monoclonal antibodies 58 Oncoscience AG 58 Interferon alpha 58 Kahalalide F 58 ART# 58 apaziquone 58 Submits Response 58 REMOXY R 58 Perflubutane Polymer Microspheres 58 Cellegesic 58 epoetin zeta 58 Pimavanserin 58 Telavancin 58 Phase 1b trial 58 Aganocide ® 58 PEG PAL 58 sapropterin dihydrochloride 58 erlotinib Tarceva R 58 Spiegelmer 58 Phase Ib clinical trials 58 RTP #i 58 molecular chaperone regulation 58 Virulizin R 58 Asentar TM 58 Fentanyl TAIFUN R 58 adipiplon 58 Safinamide 58 BLP# Liposome Vaccine 58 investigational therapies 58 therapeutic peptide 58 HP Acthar Gel repository 58 Mipomersen 58 Hexvix ® 58 humanized anti 58 antibody MT# 58 oropharyngeal candidiasis 58 anticancer therapeutics 58 teriflunomide 58 highly purified pasteurized 58 rThrombin 58 MAXY G# 58 TO AVOID PREGNANCY WHILE 58 EGS# 58 Phase 2a clinical trials 58 Sanvar R 58 cancer neuroendocrine tumor 58 Phase lll 58 Granted Orphan Drug 58 Chimigen TM 58 BrachySil TM 58 Vectibix panitumumab 58 oral salmon calcitonin 58 Aviptadil 58 MAXY VII 58 RELISTOR ® 58 tezampanel NGX# 58 evaluating satraplatin 58 ® bortezomib 58 hypoxia selective 58 Phase 1a clinical 58 PROSTASCINT R 58 vinorelbine emulsion 58 Rhucin ® 58 vascular disrupting agents 58 mesylate tablets approved 58 chemotherapy induced neutropenia 58 Linjeta ™ 58 Varespladib 58 investigational hepatitis C 58 Nanobody R 58 MyVax ® 58 Esbriet pirfenidone 58 OMP #M# 58 Menerba 58 dextofisopam 58 PF # [002] 58 PDE# inhibitors 58 ALN HPN 58 topical non steroidal 58 Capesaris 58 QuatRx 58 R PEG uricase 58 REBETOL combination therapy 58 sorafenib tablets 58 Voreloxin 58 erlotinib Tarceva ® 58 MKC# MKC# PP 58 Phase #b/#a 58 brentuximab 58 Fortigel 58 oral methylnaltrexone 58 Cintredekin Besudotox 58 CVac 58 KSP inhibitor 58 R#/MEM # 58 small molecule glucokinase 58 Prodarsan ® 58 Phenoptin 58 voclosporin 58 ORTHOVISC mini 58 Orphan Drug status 58 Intraject 58 BENLYSTA TM 58 fosbretabulin 58 Marketing Authorization Applications 58 aurora kinase 58 cell lymphoma CTCL 58 WILEX AG 58 Targretin capsules 58 novel peptide 58 Phase 1b clinical trials 58 candidate TNFerade biologic 58 Presents Preclinical 58 Androxal TM 58 Ruconest 58 nasal calcitonin product 58 oxymorphone ER 58 maribavir 58 rusalatide acetate 58 Treanda 58 non alcoholic steatohepatitis 58 PEGPH# 58 COLAZAL R 58 tafamidis 58 valopicitabine 58 sodium glucose cotransporter 58 pafuramidine maleate 58 Shigamabs ® 58 neuropathic pain metabolic diseases 58 octreotide acetate 58 Aplidin 58 Tß4 58 NerPharMa 58 refractory gout 58 platforms GVAX 58 Selvita 58 S1P antibody 58 oral taxane 58 Orphan Drug designation 58 SAR# [004] 58 paclitaxel Taxol ® 58 HuLuc# 58 Cimzia certolizumab pegol 58 Selective Electrochemical Tumor Ablation 58 Intermezzo ® zolpidem tartrate 58 Zalbin 58 Pertuzumab 58 Novolimus 58 PORxin TM 58 bortezomib Velcade 58 Neo Kidney Augment ™ 58 amifampridine phosphate 58 Exelixis compounds 58 novel L DOS# 58 corticosteroid dexamethasone 58 pan histone deacetylase 58 CAMPATH 58 PEGylated Fab fragment 58 Urocidin TM 58 TRISENOX ® 58 JOULFERON 58 proprietary polysaccharide 58 Surfaxin LS 58 Bezielle 58 factor VIIa 58 metaglidasen 58 product platforms AZX# 58 Nasdaq PARD 58 personalized cellular immunotherapy 58 Phase IIIb clinical 58 GTC NASDAQ GTCB 58 HCV protease inhibitor 58 ADVEXIN p# therapy 58 NP2 Enkephalin 58 Tarvacin TM 58 novel synthetic peptide 58 molecular imaging radiopharmaceuticals 58 fusion enhancers 58 PS# DARA 58 orBec ® oral beclomethasone 58 patented Bioral 58 E1 INT TM 58 bortezomib Velcade R 58 ongoing Phase 1b 58 Taxotere docetaxel 58 Factor Xa inhibitor 58 Huntexil 58 Lisofylline LSF 58 theranostic 58 AKT inhibitor 58 Aganocide 58 Albugon 58 pediatric pontine glioma 58 OMAPRO ™ 58 Gentamicin Surgical Implant 58 dihydrochloride 58 Proellex TM 58 Hybridon 58 L BLP# 58 Janus Kinase 58 Camvia 58 immunological diseases 58 Acapodene 58 NeuroSTAT ® 58 INT# [002] 58 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 58 Preotact R 58 GRN# 58 novel MetAP 2 58 Alocrest 58 Receives Orphan Drug 58 long acting muscarinic 58 Dificid 58 NVA# 58 Insmed Incorporated NASDAQ INSM 58 Epratuzumab 58 selective kinase inhibitor 58 Clofarabine 58 ELACYT 58 Quinamed 58 Bioral Amphotericin B 58 Genasense ® oblimersen 57 Convivia TM 57 developing Bicifadine serotonin 57 Duromist ™ 57 monoclonal antibody MAb 57 FUSILEV ® 57 NicVAX TM 57 vemurafenib 57 orally inhaled 57 MOZOBIL 57 tranilast 57 Bicifadine 57 mTOR inhibitor 57 ADVEXIN 57 SUMAVEL 57 anti angiogenic agent 57 Dalbavancin 57 sumatriptan DosePro 57 Memryte 57 LidoPAIN SP 57 oral nucleoside analogue 57 selective orally bioavailable 57 biased ligand 57 Neo Kidney Augment 57 ChemGenex Pharmaceuticals Limited 57 protein kinase inhibitor 57 polymerase inhibitor 57 AERx iDMS 57 Ocrelizumab 57 Proquin XR 57 polyclonal antibody 57 Pafuramidine 57 TRX1 57 Inc. Nasdaq VIAP 57 multiple myeloma MM 57 amrubicin 57 CIP TRAMADOL ER 57 SILENOR TM 57 EVIZON TM squalamine lactate 57 Orapred ODT 57 TELCYTA 57 Liprotamase 57 Tostrex 57 Uplyso 57 Azedra 57 LHRH antagonists 57 ularitide 57 histone deacetylase inhibitor 57 adrenergic regulation 57 Lixivaptan 57 ONCONASE R 57 Junovan 57 CG# [003] 57 Reports Preclinical Data 57 Arzerra ofatumumab 57 Multiple Ascending Dose 57 product platforms GVAX 57 Benlysta belimumab 57 Cimzia TM 57 antimitotic 57 5 FU leucovorin 57 injectable investigational 57 Liposomal 57 TEMODAL 57 Premarket Approval Application 57 maturation inhibitor 57 cannabinor 57 Actemra tocilizumab 57 Rebif ® 57 Erbitux cetuximab 57 compound INCB# 57 4SC AG ISIN DE# 57 Noscira 57 OvaRex 57 orBec R oral beclomethasone 57 Diamyd R 57 novel oral anticoagulant 57 TRIOLEX ™ 57 chimeric monoclonal antibody 57 sodium Injection 57 phase IIb 57 candidate AP# 57 Abiraterone acetate 57 Collategene 57 Survivin antagonist 57 Atripla combines 57 LEVADEX TM 57 Aegera 57 candidate epratuzumab 57 RIGScan ™ 57 Somatuline Depot 57 Sopherion 57 Therapeutic Competitors companiesandmarkets.com adEgemonye 57 treat male hypogonadism 57 Lupuzor 57 Vaccinex 57 Centralized Procedure 57 InterfeRx 57 Fludara ® 57 Phase 2a trial 57 deforolimus 57 monoclonal antibody mAb 57 Teysuno 57 fipamezole 57 ZADAXIN ® 57 tivozanib 57 Nasulin ™ 57 Kepivance 57 MT# MEDI 57 Diamyd ® 57 Asentar 57 BRAF inhibitor 57 OLEPTRO 57 lead molecular radiotherapeutic 57 Shigamabs R